论文部分内容阅读
[目的 ]进一步了解胃癌病人的机体免疫状况 ,为胃癌病人的诊断、治疗及预后提供新的依据 .[方法 ]采用酶标双抗体夹心酶联免疫吸附测定法对 5 7例胃癌病人血清可溶性白细胞介素 2受体的水平进行了检测 ,并与 40例健康者进行对照 .[结果 ]胃癌病人血清中白细胞介素 2受体含量高于正常对照组 ;对术后标本根据国际TNM分期归类 ,发现Ⅲ ,Ⅳ期胃癌病人血清中的白细胞介素 2受体水平高于Ⅰ ,Ⅱ期胃癌病人 .[结论 ]白细胞介素 2受体水平的检测对胃癌病人在免疫诊断学方面及指导外科临床治疗方面具有价值
[Objective] To further understand the immune status of patients with gastric cancer and provide new evidence for the diagnosis, treatment and prognosis of gastric cancer patients. [Methods] Enzyme-labeled double antibody sandwich enzyme-linked immunosorbent assay for serum soluble white blood cells in 57 patients with gastric cancer The level of interleukin 2 receptor was detected and compared with 40 healthy subjects. [Results] The serum level of interleukin 2 receptor in gastric cancer patients was higher than that of the normal control group; the postoperative specimens were classified according to the international TNM staging ,We found that the levels of interleukin-2 receptor in serum of patients with stage III and IV gastric cancer were higher than those in patients with stage I and II gastric cancer. [Conclusion] Detection of interleukin-2 receptor level in patients with gastric cancer in immunodiagnostics and surgical guidance Clinical treatment has value